BRCA Mutations in the Manifestation and Treatment of Ovarian Cancer

Oncotarget - United States
doi 10.18632/oncotarget.18280
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Phase 1 Trial of Olaparib and Oral Cyclophosphamide in BRCA Breast Cancer, Recurrent BRCA Ovarian Cancer, Non-Brca Triple-Negative Breast Cancer, and Non-Brca Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Germline BRCA, Chemotherapy Response Scores, and Survival in the Neoadjuvant Treatment of Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

BRCA Germline Mutations in an Unselected Nationwide Cohort of Chinese Patients With Ovarian Cancer and Healthy Controls

Gynecologic Oncology
GynecologyOncologyObstetrics
2018English

BRCA and Early Events in the Development of Serous Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2014English

BRCA Mutations in Women With Inflammatory Breast Cancer

Cancer
Cancer ResearchOncology
2017English

Prophylactic Mastectomy for BRCA Mutation Carriers After Ovarian Cancer Treatment: Is It Beneficial?

Expert Review of Anticancer Therapy
OncologyPharmacology
2018English

UK BRCA Mutation Testing in Patients With Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

CBP Truncating Mutations in Ovarian Cancer

Journal of Medical Genetics
Genetics
2005English

Risk-Reducing Salpingo-Oophorectomy and Ovarian Cancer Screening in 1077 Women After BRCA Testing

JAMA Internal Medicine
Internal Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy